FUSION SURGERY LIMITED

Company number 13130276 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

FUSION SURGERY LIMITED - Analysis Report

Company Number: 13130276

Analysis Date: 2025-07-20 18:09 UTC

Financial Health Assessment Report for Fusion Surgery Limited
As of Financial Year End 31 March 2024


1. Financial Health Score: Grade A-

Explanation:
Fusion Surgery Limited shows strong financial vitality with substantial improvement in liquidity and net assets over the last year. The company’s cash reserves have more than doubled, current liabilities have significantly decreased, and equity has grown robustly. These factors collectively indicate a healthy financial condition, though some caution is warranted due to the sharp reduction in debtors, which may affect future cash inflows if not managed carefully.


2. Key Vital Signs

Metric 2024 Value Interpretation
Cash at Bank £361,208 Very healthy cash flow ("strong pulse"); excellent liquidity to cover short-term obligations.
Current Assets £385,026 Overall good short-term resources; closely linked to liquidity strength.
Debtors (Receivables) £23,818 Sharp decrease from £197,595 in prior year; may indicate improved collections or reduced sales.
Current Liabilities £56,076 Marked reduction from £148,682; reduced "financial strain" and improved working capital.
Net Current Assets (Working Capital) £328,950 Strong positive working capital means the company can comfortably meet short-term debts.
Net Assets (Equity) £330,021 Healthy and growing shareholder funds; indicates retained earnings and financial stability.
Tangible Fixed Assets £1,428 Minimal fixed assets; typical for service-based medical practice.
Share Capital £100 Nominal capital base; typical for small private companies.
Staff Numbers 4 employees Small team size consistent with micro/small category; likely efficient operation.

3. Diagnosis: What the Financial Data Reveals

Fusion Surgery Limited exhibits "robust cardiovascular health" financially. The company demonstrates a strong liquidity position with ample cash reserves, which is a crucial "heartbeat" indicator signaling the capacity to cover immediate liabilities comfortably and invest in operations or future growth without liquidity stress.

The significant reduction in trade debtors from £197,595 to £23,818 suggests two possible "symptoms": either the company has improved its credit control and cash collection processes, leading to faster cash inflows, or it has experienced a drop in sales or invoiced services. Given the healthy cash position, improved collections seem more likely, which is positive, but the business should monitor this carefully to avoid future revenue shortfalls.

Current liabilities have decreased substantially, reducing the "pressure on the heart" in terms of short-term debts. This improvement in working capital signals effective management of payables and cash flow.

Net assets have grown by approximately £127,000 year-over-year, reflecting retained earnings accumulation and a solid equity base. This indicates "muscle strength" in the balance sheet and provides a cushion against potential future shocks.

The company operates in the general medical practice sector, a typically stable industry with ongoing demand, supporting a favorable "prognosis."


4. Recommendations: Specific Actions to Improve Financial Wellness

  • Maintain and Monitor Receivables: The sharp drop in debtors warrants careful monitoring. Ensure that revenue streams remain consistent and that credit policies continue to promote timely collections without compromising patient or client relationships.

  • Cash Flow Management: Continue to build on strong cash reserves but consider investing in growth or improvements in operational capacity (e.g., equipment or staff training) to sustain long-term health.

  • Expense Control: With reduced current liabilities, maintain discipline in managing payables and operating costs to preserve working capital strength.

  • Strategic Investment: Given the low level of fixed assets, evaluate potential investment in medical equipment or technology to enhance service delivery and competitive positioning.

  • Regular Financial Reviews: Conduct periodic financial health checks to identify any early "symptoms" of distress, especially given the evolving healthcare landscape.

  • Governance and Compliance: Ensure ongoing compliance with filing deadlines and regulatory requirements to avoid penalties or disruptions.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.